Zimmer Biomet (ZBH) PT Lowered to $140 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Zimmer Biomet (ZBH) PT Lowered to $155 at Needham & Company as They See Conservative Guidance
January 21, 2022 7:03 AM ESTNeedham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $158.00) while maintaining a Buy rating as they expect conservative 2022 guidance following management comments at a recent investor conference.
The analyst commented, "Based on management comments at... More
